EU Parliament poised to reject two Esma technical standards on OTC derivatives

Parliament is unhappy with the treatment of corporate end-users, and could require Esma to redraft standards

Rejected Link Request

The European Parliament's Economic and Monetary Affairs (Econ) Committee will vote on February 4 whether to reject two key regulatory technical standards on over-the-counter derivatives and central counterparty (CCP) requirements – a potentially significant hurdle for timely implementation of the European Market Infrastructure Regulation (Emir).

If the Econ committee approves the resolution to reject the standards, it will trigger a full plenary vote in parliament, which could result in the

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options


Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here